The Amyloidosis Research Consortium is a nonprofit accelerating the development of and access to new and innovative treatments. We are driving the research that will have the greatest impact on length and quality of life for patients.
Latest news from ARC
Announcing our Educational Booklet Series!
Quality and reliable information has always been a focus of the Amyloidosis Research Consortium (ARC). When patients are first diagnosed, it’s hard to know where to turn to learn about your options and what may lie ahead.
Coronavirus: What Amyloidosis Patients Should Know
With the rise in cases of COVID-19, and the risks posed to some amyloidosis patients, ARC is monitoring recommendations and resources.
My Amyloidosis Pathfinder
MAP is a free, easy-to-use tool that captures your treatment preferences, goals, and challenges so you can effectively communicate with your amyloidosis care teams. You can also find and compare specialty treatment centers and receive personalized matches to clinical trials.Get Started